Refine your search
Collections
Co-Authors
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Garud, Aniket
- Hypoglycemic and Antihyperglycemic Prospective of marketed and Herbal Resilient Mediators
Abstract Views :149 |
PDF Views:0
Authors
Affiliations
1 Department of Pharmacy, Ponnaiyah Ramajayam Institute of Science and Technology (PRIST University) Vallam, Thanjavur, Tamil Nadu, IN
2 Department of Pharmacy, Dr. D. Y. Patil College of Pharmacy, Pune, Maharashtra, IN
1 Department of Pharmacy, Ponnaiyah Ramajayam Institute of Science and Technology (PRIST University) Vallam, Thanjavur, Tamil Nadu, IN
2 Department of Pharmacy, Dr. D. Y. Patil College of Pharmacy, Pune, Maharashtra, IN
Source
Research Journal of Pharmacy and Technology, Vol 12, No 6 (2019), Pagination: 3012-3016Abstract
Diabetes is drumming worldwide to not only developed countries but developing countries too. Many combinations and Antidiabetic drugs are available in the market which claims effective management of blood glucose levels. One must study how the effectively and accuracy of the same scientifically. Ayurveda is the longest and strongest mother source for all treatments of numerous ailments. In Ayurveda a separate section called as Rasayana Chikista is meant for antiaging as well as rejuvenation. Curcumin is the major conqueror molecule which has shown the promising effect toward various ailments. Ginger is also Rasayana Herb. Allium sativum that is Garlic is best known for its antibacterial activity as well as lipid lowering activity. Here we would like to test and evaluate comparative status of various marketed and herbal Antidiabetic drugs. Different animal models claim different mechanism which is quite comparable to several diabetic conditions of patient.Keywords
Diabetes, Marketed and Herbal drugs, Comparison, OGTT, Hypoglycemia.
References
- Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Emerging Risk Factors Collaboration. Lancet. 2010; 26;375:2215-2222.
- Epidemiology of kidney disease in the United States. United States Renal Data System. USRDS Annual data Report, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2014:188–210.
- Finucane MM, Danaei G, Ezzati M. Bayesian estimation of population-level trends in measures of health status. Statistical Sciences. 2014;29,18–25.
- Global status report on non-communicable diseases 2014. Geneva: World Health Organization.
- Samy Hadjadj, Frédéric Fumeron, Ronan Roussel, Pierre Jean Saulnier, Yves Gallois, Amos Ankotche, Florence Travert, Charbel Abi Khalil, Aurélie Miot, François Alhenc-Gelas, Michel Lievre, Michel Marre. Prognostic Value of the Insertion/Deletion Polymorphism of the ACE Gene in Type 2 Diabetic Subjects Diabetes Care Sep 2008, 31 (9) 1847-1852; DOI: 10.2337/dc07-2079.
- JF Gautieret, al. Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetes. Diabetes & Metabolism. Volume 31, Issue 3, June 2005, Pages 233-242.
- C. Moreau, D. Drui, G. Arnault-Ouary, B. Charbonnel, B. Cariou. Fulminant type 1 diabetes in Caucasians: A report of three cases. Diabetes & Metabolism. Volume 34, Issue 5, November 2008, Pages 529-532.
- Wen‐Hsuan Hou, Chung‐Yi Li, Lu‐Hsuan Chen, Liang‐Yi Wang, Ken N. Kuo, Hsiu‐Nien Shen and Ming‐Fong Chang, Prevalence of hand syndromes among patients with diabetes mellitus in Taiwan: A population‐based study, Journal of Diabetes.2016, 9(6), 622-627.
- S. Ravindran Rajendran, A. Bhansali, R. Walia, P. Dutta, V. Bansal and G. Shanmugasundar, Prevalence and pattern of hand soft-tissue changes in type 2 diabetes mellitus, Diabetes & Metabolism. 2011, 37(4), 312-318.
- Hur, Kyu Yeon and Myung-ShikLee. Gut Microbiota and Metabolic Disorders. Diabetes & metabolism journal. 2015, 39(3), 198-203.
- Bagde AB, Sa want RS, Nikumbh MB, Kale AB, Dhimdhime R S. Rasayana chikista: Antiagening therapy of Ayurveda. Int. Res. J. Pharm. 2013; 4(4):64-69.
- Rasayana: Ayurvedic Herbs for Longevity and Rejuvenation: Volume 2 of Traditional Herbal Medicines for Modern Times. 9(2), pp. 331–332.
- Curcuma Longa L. Plants of the World Online, Kew Science, Kew Gardens, Royal Botanic Gardens, Kew, England. 2018. Retrieved 26 March 2018.
- Turmeric: Merriam-Webster Dictionary. 2015.
- Peter, K. V. et, al. Underutilized and Underexploited Horticultural Crops, New India Publishing. (2008), Volume 2. p. 341
- COUNCIL OF EUROPE: Ginger-Zingiberis rhizome. In: European Pharmacopoeia, 6th ed, 2009.
- Hikono H., Wagner H, Hikino H, Farnsworth NR, et al. Recent research on oriental Medicinal plants. In: Economic and Medicinal Plant Research (ed) Academic Press, London, 1985, 53-85.
- Terry R, Watson LK, Posadzki P, et al. The use of Ginger (Zingiber officinale) for the treatment of pain: A systematic review of clinical trials. Pain Medicine. (2011). 12 (12): 1808–1818.
- Ernst E, Pittler M et al. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. British Journal of Anesthesia. (2000).(4), 344-348.
- Palaksha MN, Ahmed M, Das S. Antibacterial activity of garlic extract on streptomycin-resistant Staphylococcus aureus and Escherichia coli solely and in synergism with streptomycin. J Nat Sci Biol Med. 2010, 1(1):12-5.
- Ried K, Toben C, Fakler P, et al, Effect of garlic on serum lipids: an updated meta-analysis. Nutrition Reviews 2013; 71(5): 282-299.
- Vlasakakis G, Pasqua OD. Cardiovascular disease: the other face of diabetes. CPT Pharmacometrics Syst Pharmacol. (2013), 2(10): e81. doi: 10.1038/psp.2013.57
- Turati Federica, Guercio Valentina, Pelucchi Claudio, La Vecchia, Carlo Galeone Carlotta. Colorectal cancer and adenomatous polyps in relation to allium vegetables intake: A meta-analysis of observational studies". Molecular Nutrition & Food Research. (2014). 58 (9): 1907–1914.
- Sun, Yue-E, Wang Weidong et al. Anti-hyperlipidemia of garlic by reducing the level of total cholesterol and low-density lipoprotein. Medicine: (2018) 97, 18, e0255. doi: 10.1097/MD. 0000000000010255.
- Ecobichon DJ. The Basis of Toxicology Testing. New York: CRC Press; 1997. 43–86.
- OECD Test No. 425: Acute Oral Toxicity: Up-and-Down Procedure, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris (2008). https://doi.org/10.1787/ 9789264071049-en.
- Khadke, S.S. & Pachauri, D.R. & Mahajan, S.D. An Acute Oral Toxicity Study of Gnidiaglauca (Fresen.) Gilg. in Albino Rats as per OECD Guideline 425. International Journal of Pharm Tech Research. (2011) 3,787-791.
- Shalini Adiga, K. L. Bairy, A. Meharban, I. S. R. Punita Hypoglycemic effect of aqueous extract of Trichosanthesdioica in normal and diabetic rats. Int J Diabetes Dev Ctries. 2010 Jan-Mar; 30(1): 38–42. doi: 10.4103/0973-3930.60011.
- Deore S L, Khadabadi S S, Daulatkar V D, Deokate U A, Farooqui I U. Evaluation of hypoglycemic and antidiabetic activity of bark of Buteamonosperma. Phcog Mag 2008;4:134-138.
- Carai MA, Colombo G, Loi B, Zaru A, Riva A, Cabri W, Morazzoni P. Hypoglycemic effects of a standardized extract of salvia miltiorrhiza ischolar_mains in rats . Phcog Mag 2015;11, Suppl S4:545-9.
- Rahul Chandran et al. Antihyperglycemic activity of the bark methanolic extract of Syzygiummundagam in diabetic rats. Alexandria Journal of Medicine (2017), 53, 317–324.
- Venkatesh S, Reddy GD, Reddy YSR, Sathyavathy D, Reddy BM. Effect of Helicteresisora ischolar_main extracts on glucose tolerance in glucose-induced hyperglycemic rats. Fitoterapia. 2004;75:364–367.
- One-way ANOVA followed by Dunnett’s multiple comparisons test was performed using GraphPad Prism version 6.01 for Windows, GraphPad Software, La Jolla California USA, www.graphpad.com .
- Amira Klip, Lawrence A Leiter. Cellular Mechanism of Action of Metformin. Diabetes Care Jun 1990, 13 (6) 696-704; DOI: 10.2337/diacare.13.6.696.
- Zdrav Vestn. Metformin: from mechanisms of action to advanced clinical use 2017; 86: 138–57.
- Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577-1585.
- Bojkova, B., Orendas, P., Garajova, M., Kassayova, M., Kutna, V., Ahlersova, E., and Ahlers, I. Metformin in chemically-induced mammary carcinogenesis in rats. Neoplasma. (2009) 56, 269-274.
- Minamii, T. ,Nogami, M. and Ogawa, W. (2018), Mechanisms of metformin action: In and out of the gut. J Diabetes Investig, 9: 701-703. doi:10.1111/jdi.12864.
- Waget et al. Sitagliptin Mode of Action. Endocrinology, August 2011, 152(8):0000–0000
- Gallwitz, Baptist. Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update). Drugs of today (Barcelona, Spain : 1998). (2007). 43. 801-14. 10.1358/dot.2007.43.11. 1157620.
- Gallwitz B. Review of sitagliptin phosphate: a novel treatment for type 2 diabetes. Vasc Health Risk Manag. 2007;3(2):203-10.
- Carolina Solis-Herrera et al. Mechanisms of Glucose Lowering of Dipeptidyl Peptidase-4 Inhibitor Sitagliptin When Used Alone or With Metformin in Type 2 Diabetes. Diabetes Care (2013)36:2756–2762.
- F.J. Ortegaetal. ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia–ischemia in rats. Experimental Neurology (2012)235,1, , 282-296.
- Xenón Serrano-Martín, Gilberto Payares, Alexis Mendoza-León. Glibenclamide, a Blocker of K+ATP Channels, Shows Antileishmanial Activity in Experimental Murine Cutaneous Leishmaniasis. Antimicrobial Agents and Chemotherapy (2006), 50 (12) 4214-4216;DOI:10.1128/AAC.00617-06.
- Shoichiro Nagasaka, Ataru Taniguchi, Yoshitaka Aiso, Toshimitsu Yatagai, Tomoatsu Nakamura, Yoshikatsu Nakai, Mitsuo Fukushima, Akira Kuroe, Shun Ishibashi. Effect of Glimepiride on Serum Adiponectin Level in Subjects With Type 2 Diabetes. Diabetes Care Jul 2003, 26 (7) 2215-2216; DOI: 10.2337/diacare.26.7.2215.
- Barbara Salani et al. Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent. Biochemical and Biophysical Research Communications. (2005), Volume 335, Issue 3, Pages 832-835.
- Ariela Benigni, Carla Zoja, Susanna Tomasoni, Marco Campana, Daniela Corna, Cristina Zanchi, Elena Gagliardini, Elvira Garofano, Daniela Rottoli, Takahito Ito, Giuseppe Remuzzi. Transcriptional Regulation of Nephrin Gene by Peroxisome Proliferator–Activated Receptor-γ Agonist: Molecular Mechanism of the Antiproteinuric Effect of Pioglitazone. JASN Jun 2006, 17 (6) 1624-1632; DOI: 10.1681/ASN.2005090983.
- Minoru Iwata, Tetsuro Haruta, Isao Usui, Yasumitsu Takata, Atsuko Takano, Tatsuhito Uno, Junko Kawahara, Eiichi Ueno, Toshiyasu Sasaoka, Osamu Ishibashi, Masashi Kobayashi. Pioglitazone Ameliorates Tumor Necrosis Factor-α–Induced Insulin Resistance by a Mechanism Independent of Adipogenic Activity of Peroxisome Proliferator–Activated Receptor-γ. Diabetes May 2001, 50 (5) 1083-1092; DOI: 10.2337/diabetes.50.5.1083.
- Santiago Redondo, Emilio Ruiz, Carlos G. Santos-Gallego, Eugenia Padilla, Teresa Tejerina. Pioglitazone Induces Vascular Smooth Muscle Cell Apoptosis Through a Peroxisome Proliferator-Activated Receptor-γ, Transforming Growth Factor-β1, and a Smad2-Dependent Mechanism. Diabetes Mar 2005, 54 (3) 811-817; DOI: 10.2337/diabetes.54.3.811.
- Kaur, B. , Singh, N. and Jaggi, A. S. (2009), Exploring mechanism of pioglitazone‐induced memory restorative effect in experimental dementia. Fundamental & Clinical Pharmacology, 23: 557-566. doi:10.1111/j.1472-8206.2009.00708.x.
- Kulkarni SK, Dhir A. An overview of curcumin in neurological disorders. Indian J Pharm Sci.2010;72(2):149-54.
- Mishra S, Palanivelu K. The effect of curcumin (turmeric) on Alzheimer's disease: An overview. Ann Indian Acad Neurol. 2008;11(1):13-9.
- Prabhakar SS Effects of curcumin in experimental diabetic nephropathy Journal of Investigative Medicine 2017;65:1-6.
- Yu W, Wu J, Cai F, Xiang J, Zha W, Fan D, et al. (2012) Curcumin Alleviates Diabetic Cardiomyopathy in Experimental Diabetic Rats. PLoS ONE 7(12): e52013. https://doi.org/10.1371/ journal. pone. 0052013.
- Mahmmoud YA. Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions. Br J Pharmacol. 2006;150(2):200-8.
- Rachana Garg, Asha G. Ramchandani, Girish B. Maru; Curcumin decreases 12- O -tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin, Carcinogenesis, Volume 29, Issue 6, 1 June 2008, Pages 1249–1257, https://doi.org/10.1093/carcin/bgn114.
- Satyabrata Pany, Youngki You, and Joydip Das. Curcumin Inhibits Protein Kinase Cα Activity by Binding to Its C1 Domain. Biochemistry 2016,55 (45),6327-6336 DOI: 10.1021/acs.biochem. 6b00932.
- Aniket Garud et al. Macrophage Phagocytic Index: Approach in understanding of diabetes and related complication. Journal of Pharmacy Research 2011, 4(8),2849-2852.
- Garud et al. Effect of Combination of Ursolic Acid and Glibenclamide on Macrophage Phagocytic Index in Alloxan induced Diabetic Rats. World Journal Of Pharmacy And Pharmaceutical Sciences. (2014)3,10, 622-630.
- R.M. Hashem et al. Effect of 6-gingerol on AMPK- NF-kB axis in high fat diet fed rats Biomedicine & Pharmacotherapy 88 (2017) 293–301.
- El-Bassossy, H. M., Elberry, A. A., Ghareib, S. A., Azhar, A., Banjar, Z. M., & Watson, M. L. Cardioprotection by 6-gingerol in diabetic rats. Biochemical and Biophysical Research Communications.(2016).477(4),908-914. doi.org/10.1016/j.bbrc. 2016.06. 157.
- Yi Shao, Yao Yu, Cheng Li, Jing Yu, Rongrong Zong and Chonggang Pei, Synergistic effect of quercetin and 6-gingerol treatment in streptozotocin induced type 2 diabetic rats and poloxamer P-407 induced hyperlipidemia, RSC Advances, (2016)6, 15,(12235).
- Deepmala Joshi, Sunil Kumar Srivastav, Sateesh Belemkar and Vaibhav A. Dixit, Zingiber officinale and 6-gingerol alleviate liver and kidney dysfunctions and oxidative stress induced by mercuric chloride in male rats: A protective approach, Biomedicine & Pharmacotherapy,(2017)91,(645).
- Xiangyi Kong et al. Neuroprotective effects of allicin on ischemia-reperfusion brain injury. Oncotarget, 2017, Vol. 8, (No. 61), pp: 104492-104507.
- Mohamed Nagui T. Attia and Magdy A. Ali. Hepatoprotective Activity of Allicin Against Carbon Tetrachloride Induced Hepatic Injury in Rats. Journal of Biological Sciences.2006,6: 457-468.
- Amitai Elkayam et al. The Effects of Allicin and Enalapril in Fructose-Induced Hyperinsulinemic Hyperlipidemic Hypertensive Rats. AJH 2001; 14:377–381.
- Amitai Elkayam et al. The Effects of Allicin on Weight in Fructose-Induced Hyperinsulinemic, Hyperlipidemic, Hypertensive Rats. AJH 2003; 16:1053–1056.
- Amitai Elkayam et al. Effects of allicin on cardiovascular risk Factors in spontaneously Hypertensive rats. IMAJ 2013,15,170-173.
- H. Dubey et al. Allicin in hypertensive rats. Integr med Res 6(2017) 60-65.
- Nabavi SF. et al. Curcumin: a natural product for diabetes and its complications. Curr Top Med Chem. 2015;15(23):2445-55.
- Somlak Chuengsamarn, Suthee Rattanamongkolgul, Rataya Luechapudiporn, Chada Phisalaphong, Siwanon Jirawatnotai. Curcumin Extract for Prevention of Type 2 Diabetes. Diabetes Care Nov 2012, 35 (11) 2121-2127; DOI: 10.2337/dc12-0116.
- Zhang DW, Fu M, Gao SH, Liu JL. Curcumin and diabetes: a systematic review. Evid Based Complement Alternat Med. 2013; 636053.